RU2015132569A - Полимиксины, композиции с ними, способы получения и способы применения - Google Patents

Полимиксины, композиции с ними, способы получения и способы применения Download PDF

Info

Publication number
RU2015132569A
RU2015132569A RU2015132569A RU2015132569A RU2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A RU 2015132569 A RU2015132569 A RU 2015132569A
Authority
RU
Russia
Prior art keywords
uhllc
methyloctanoyl
composition
methylheptanoyl
polymyxin
Prior art date
Application number
RU2015132569A
Other languages
English (en)
Russian (ru)
Inventor
Сёльви ГУННЕС
Видар БЬЁРНСТАД
Торбен Кох
Клес Меландер
Мартин МОНССОН
Original Assignee
Кселлия Фармасьютикалз Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кселлия Фармасьютикалз Апс filed Critical Кселлия Фармасьютикалз Апс
Publication of RU2015132569A publication Critical patent/RU2015132569A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
RU2015132569A 2013-01-11 2014-01-09 Полимиксины, композиции с ними, способы получения и способы применения RU2015132569A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US61/751,341 2013-01-11
US201361904793P 2013-11-15 2013-11-15
US61/904,793 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
RU2015132569A true RU2015132569A (ru) 2017-02-14

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015132569A RU2015132569A (ru) 2013-01-11 2014-01-09 Полимиксины, композиции с ними, способы получения и способы применения

Country Status (20)

Country Link
US (1) US10640536B2 (enExample)
EP (1) EP2943503B1 (enExample)
JP (1) JP6316846B2 (enExample)
KR (1) KR20150107793A (enExample)
CN (1) CN104918951B (enExample)
AU (1) AU2014204873B2 (enExample)
BR (1) BR112015016548A2 (enExample)
CA (1) CA2895910C (enExample)
EA (1) EA027067B1 (enExample)
ES (1) ES2641017T3 (enExample)
HU (1) HUE034562T2 (enExample)
IL (1) IL239840A (enExample)
MX (1) MX360905B (enExample)
PT (1) PT2943503T (enExample)
RU (1) RU2015132569A (enExample)
SI (1) SI2943503T1 (enExample)
TW (1) TWI613219B (enExample)
UA (1) UA117673C2 (enExample)
WO (1) WO2014108469A1 (enExample)
ZA (1) ZA201504565B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2895910C (en) 2013-01-11 2021-12-21 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
PT3166960T (pt) 2014-07-09 2019-10-25 Xellia Pharmaceuticals Aps Polimixinas de baixa substituição e composições das mesmas.
PL3200762T3 (pl) 2014-10-03 2019-08-30 Xellia Pharmaceuticals Aps Urządzenie do inhalacji
CN106794221B (zh) 2014-10-03 2021-12-10 埃克斯利亚制药有限公司 组合物
EP3233889B1 (en) 2014-12-16 2022-07-06 Shanghai MicuRx Pharmaceutical Co., Ltd. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
JP7367950B2 (ja) * 2015-09-29 2023-10-24 モナッシュ ユニバーシティ 抗菌性ポリミキシン誘導体化合物
WO2018103758A1 (zh) * 2016-12-09 2018-06-14 上海医药工业研究院 高效价的多黏菌素e2甲磺酸钠
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (enExample) * 1968-02-12 1970-03-06
AU611030B2 (en) * 1988-04-07 1991-05-30 Edward Shanbrom Non-thrombogenic intravascular time release catheter
CA2242335A1 (en) 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
ES2261735T3 (es) 2001-05-18 2006-11-16 Chiron Corporation Sistema para la administracion de una formulacion de tobramicina.
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
WO2007049294A1 (en) * 2005-10-28 2007-05-03 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride.
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CA2895910C (en) 2013-01-11 2021-12-21 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
PT3166960T (pt) 2014-07-09 2019-10-25 Xellia Pharmaceuticals Aps Polimixinas de baixa substituição e composições das mesmas.
CN106794221B (zh) 2014-10-03 2021-12-10 埃克斯利亚制药有限公司 组合物

Also Published As

Publication number Publication date
TWI613219B (zh) 2018-02-01
TW201429995A (zh) 2014-08-01
UA117673C2 (uk) 2018-09-10
EA027067B1 (ru) 2017-06-30
ES2641017T3 (es) 2017-11-07
HUE034562T2 (en) 2018-03-28
US10640536B2 (en) 2020-05-05
KR20150107793A (ko) 2015-09-23
AU2014204873B2 (en) 2017-07-06
BR112015016548A2 (pt) 2017-07-11
JP2016505007A (ja) 2016-02-18
MX360905B (es) 2018-11-21
JP6316846B2 (ja) 2018-04-25
IL239840A0 (en) 2015-08-31
PT2943503T (pt) 2017-09-28
US20160002296A1 (en) 2016-01-07
IL239840A (en) 2017-09-28
WO2014108469A1 (en) 2014-07-17
ZA201504565B (en) 2016-11-30
MX2015008878A (es) 2015-10-30
AU2014204873A1 (en) 2015-07-09
EA201591280A1 (ru) 2015-12-30
CN104918951B (zh) 2018-03-30
CA2895910A1 (en) 2014-07-17
SI2943503T1 (sl) 2017-11-30
EP2943503A1 (en) 2015-11-18
CN104918951A (zh) 2015-09-16
CA2895910C (en) 2021-12-21
EP2943503B1 (en) 2017-08-23

Similar Documents

Publication Publication Date Title
JP2016505007A5 (enExample)
MX385731B (es) Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas.
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
EA202090604A1 (ru) Хроманмонобактамовые соединения для лечения бактериальных инфекций
EA201800064A1 (ru) 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl
RU2015138796A (ru) Способы и составы для лечения респираторных заболеваний
FI3616695T3 (fi) Menetelmät keuhkojen sisäisten infektioiden hoitamiseksi
JP2017510580A5 (enExample)
EA201490864A1 (ru) Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов
JP2016503052A5 (enExample)
HRP20171512T1 (hr) Derivati betulina
BR112014004704A2 (pt) compostos antibacterianos e métodos de uso
EA202091118A1 (ru) Антибактериальные соединения
JP2013542992A5 (enExample)
EA201790337A1 (ru) Кристаллические формы ингибиторов глутаминазы
HRP20200938T1 (hr) Kombinacija koja sadrži zidovudin i polimiksin
EA201890771A1 (ru) Соли и твердые формы монобактамного антибиотика
EP3914595A4 (en) METHOD OF TREATMENT OF OSTEOARTHRITIS PAIN BY ADMINISTRATION OF RESINIFERATOXIN
EA201590022A1 (ru) Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса
MD20190080A2 (ro) Forme cristaline de (s)-afoxolaner
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
ME02405B (me) Spojevi pirazola као inhibitori sglt1
EA201691271A1 (ru) Соединения [1 ,2,4]триазоло[1 ,5-a]пиримидина в качестве ингибиторов протозойной протеосомы для лечения паразитарного заболевания, такого как лейшманиоз
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20171109